Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children

Brain and Development

Volumn 34, Issue 3, 2012, Pages 185-188

  Yiş, Uluç ^a   Doĝan, Mustafa ^a  

^a Gaziantep Children's Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXCARBAZEPINE; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; PEDIATRICS; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICONVULSANTS; CARBAMAZEPINE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CHILD, PRESCHOOL; EPILEPSY; HUMANS; LIPIDS;

EID: 84856950863     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.05.009     Document Type: Article

References (15)

1. Aggarwal A., Singh V., Batra S., Faridi M.M., Sharma S. Effect of carbamazepine therapy on serum lipids in children with partial epilepsy. Pediatr Neurol 2009, 40:94-97.
2. Mahmoudian T., Iranpour R., Messri N. Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy Behav 2005, 6:257-259.
3. Demircioĝlu S., Soylu A., Dirik E. Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children. Pediatr Neurol 2000, 23:142-146.
4. Franzoni E., Marchiani V., Cecconi I., Moscano F.C., Gualandi S., Garone C., et al. Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children. Eur J Neurol 2006, 13:1389-1391.
5. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
6. Nicholson J.F., Pesce M.A. Reference ranges for laboratory tests and procedures. Nelson Textbook of Pediatrics 2004, 2396-2427. Elsevier Science, Philadelphia. R.E. Behrman, R.M. Kliegman (Eds.).
7. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 6:1399-1406.
8. Isojärvi J.I., Pakarinen A.J., Rautio A., Pelkonen O., Myllylä V.V. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994, 35:1217-1220.
9. Papacostas S. Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities. J Child Neurol 2000, 15:138-140.
10. Isojärvi J.I., Pakarinen A.J., Myllylä V.V. Serum lipid levels during carbamazepine medication. A prospective study. Arch Neurol 1993, 50:590-593.
11. Patsalos P.N., Zakrzewska J.M., Elyas A.A. Does dependent enzyme induction by oxcarbazepine?. Eur J Clin Pharmacol 1900, 39:187-188.
12. Assmann G., Gotto A.M. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 15:8-14.
13. Annegers J.F., Hauser W.A., Shirts S.B. Heart disease mortality and morbidity in patients with epilepsy. Epilepsia 1984, 25:699-704.
14. Erdemir A., Cullu N., Yiş U., Demircioĝlu F., Kir M., Cakmakçi H., et al. Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain Dev 2009, 31:713-716.
15. Hamed S.A., Hamed E.A., Hamdy R., Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 2007, 74:183-192.